He Wei-Wu 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-23 5:15 pm Purchase |
2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,598,199 17.470% |
438,000 (+20.28%) |
Filing |
| 2021-02-03 4:01 pm Purchase |
2021-02-01 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,160,199 16.260% |
384,747 (+21.67%) |
Filing |
| 2020-07-29 5:16 pm Purchase |
2020-07-24 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 1,775,452 13.780% |
520,900 (+41.52%) |
Filing |